# AlloSource – FDA Inspection, Aug 30, 2022

Source: https://www.keypedia.com/records/fda_inspections/allosource/d9f545b2-a5ac-43fa-b251-c0a13b52b2d3
Source feed: FDA_Inspections

> FDA inspection 1180198 of AlloSource, August 30, 2022. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180198
- Company Name: AlloSource
- Inspection Date: 2022-08-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1012394 - 2017-05-22
- FDA Inspection 916763 - 2015-03-05
- [FDA Inspection 771277 - 2012-03-12](https://www.keypedia.com/records/fda_inspections/allosource/95c52244-2c9a-4fb0-86e9-6e077d808b28)
- FDA Inspection 659873 - 2010-04-28

Company: https://www.keypedia.com/companies/allosource/32725054-4001-4286-a064-38334040c623

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d